ENTRY       D11906                      Drug
NAME        Lirentelimab (USAN)
FORMULA     C6408H9884N1700O2006S46
EXACT_MASS  144219.0824
MOL_WEIGHT  144308.221
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFSLT IYGAHWVRQA PGKGLEWVGV IWAGGSTNYN
            SALMSRFTIS KDNSKNTVYL QMNSLRAEDT AVYYCARDGS SPYYYSMEYW GQGTTVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
            (Light chain)
            EIVLTQSPAT LSLSPGERAT LSCSATSSVS YMHWFQQKPG QAPRLLIYST SNLASGIPAR
            FSGSGSGTDF TLTISSLEPE DFAVYYCQQR SSYPFTFGPG TKLDIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bride: H22-H95, H147-H203, H223-L213, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'95, H'147-H'203, H'223-L'213, H'264-H'324, H'370-H'428, L23-L87, L133-L193, L'23-L'87, L'133-L'193)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Anti-Siglec-8 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of eosinophilic gastrointestinal diseases, systemic mastocytosis, chronic urticaria, and/or severe allergic conjunctivitis
TARGET      SIGLEC8 [HSA:27181] [KO:K06748]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               SIGLEC family
                SIGLEC8
                 D11906  Lirentelimab (USAN)
DBLINKS     CAS: 2283348-97-8
///
